Bayzed Health Group, Inc.

As of December 31, 2025, Bayzed Health Group, Inc. carries a market capitalization of 5.04B, placing it among publicly traded companies globally. Its enterprise value stands at 5.08B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2025, Bayzed Health Group, Inc. has 1.32B shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Bayzed Health Group, Inc. maintains a current ratio of 1.69, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Bayzed Health Group, Inc.'s stock has declined approximately 63.35% over the past 52 weeks. The 50-day moving average sits at 2.93, while the 200-day moving average is 3.77.

As of December 31, 2025, Bayzed Health Group, Inc. holds 675.92M in cash and equivalents against 605.86M in total debt, resulting in a net debt position of -229.45M. Total book value stands at 1.69B, with working capital of 525.36M providing operational flexibility.